Amyloidosis and device therapy: an open debate

Salvatore Novo, Egle Corrado, Eluisa La Franca, Gianfranco Ciaramitaro, Giuseppe Coppola, Giuseppe Inga

Research output: Contribution to journalArticlepeer-review


Cardiac involvement represents a critical prognostic factor inamyloidosis, as it represents a leading cause of morbidity and mortality,in primary light chain amyloidosis, in hereditary and alsoin wild-type transthyretin amyloidosis. A 54-year-old male wasadmitted to Emergency Room with complaints of dyspnea, palpitationsand diaphoresis.
Original languageEnglish
Pages (from-to)497-498
Number of pages2
JournalInternational Angiology
Publication statusPublished - 2017

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Amyloidosis and device therapy: an open debate'. Together they form a unique fingerprint.

Cite this